Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New monthly shot aims to keep schizophrenia symptoms at bay

NCT ID NCT06961968

Disease control Sponsor: Vanda Pharmaceuticals Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a long-acting injection of iloperidone can delay or prevent the return of schizophrenia symptoms compared to a placebo injection. About 400 adults with schizophrenia who need ongoing treatment will receive either the drug or a placebo and be monitored for how long it takes for symptoms to worsen. The goal is to see if this monthly shot helps people stay stable longer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Males or females 18 to 65 years of age (inclusive) * Diagnosed with schizophrenia per DSM-5 criteria * In need of ongoing psychiatric treatment Exclusion Criteria: * DSM-5 diagnosis of a psychiatric disorder other than schizophrenia that was the primary focus of treatment within the previous six months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Schizophrenia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

schizophrenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Schizophrenia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The study's own enquiry address

    This study publishes an address for enquiries. See it below .

  2. The places running it

    22 sites. The list below names each one and where it is.

  3. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  4. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Vanda Investigational Site

    RECRUITING

    Rogers, Arkansas, 72758, United States

  • Vanda Investigational Site

    RECRUITING

    Costa Mesa, California, 92626, United States

  • Vanda Investigational Site

    RECRUITING

    Lemon Grove, California, 91945, United States

  • Vanda Investigational Site

    RECRUITING

    Oceanside, California, 92056, United States

  • Vanda Investigational Site

    RECRUITING

    Pico Rivera, California, 90660, United States

  • Vanda Investigational Site

    RECRUITING

    San Diego, California, 92123, United States

  • Vanda Investigational Site

    RECRUITING

    Walnut Creek, California, 94596, United States

  • Vanda Investigational Site

    RECRUITING

    North Miami, Florida, 33161, United States

  • Vanda Investigational Site

    RECRUITING

    Atlanta, Georgia, 30328, United States

  • Vanda Investigational Site

    RECRUITING

    Peachtree Corners, Georgia, 30071, United States

  • Vanda Investigational Site

    RECRUITING

    Chicago, Illinois, 60641, United States

  • Vanda Investigational Site

    RECRUITING

    Flowood, Mississippi, 39232, United States

  • Vanda Investigational Site

    RECRUITING

    Saint Charles, Missouri, 63304, United States

  • Vanda Investigational Site

    RECRUITING

    St Louis, Missouri, 63141, United States

  • Vanda Investigational Site

    RECRUITING

    Las Vegas, Nevada, 89119, United States

  • Vanda Investigational Site

    RECRUITING

    Marlton, New Jersey, 08053, United States

  • Vanda Investigational Site

    RECRUITING

    Staten Island, New York, 10314, United States

  • Vanda Investigational Site

    RECRUITING

    Austin, Texas, 78754, United States

  • Vanda Investigational Site

    RECRUITING

    Houston, Texas, 77081, United States

  • Vanda Investigational Site

    RECRUITING

    Irving, Texas, 75062, United States

  • Vanda Investigational Site

    RECRUITING

    Richardson, Texas, 75080, United States

  • Vanda Investigational Site

    RECRUITING

    Bellevue, Washington, 98007, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.